Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

0.0995 -0.0161 (-13.93%)
Official Closing Price Updated: 6:30 PM EDT, Jul 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
Top movers in Monday's after hours session ↗
Via Chartmill
Study Links Gut Microbial Metabolites to Enhanced Cancer Immunotherapy Sensitivity
Via Investor Brand Network
Understanding Why Treatment Resistance Exists in Many Cancers
Via Investor Brand Network
AI Tool Predicts the Optimal Presurgical Treatments for Breast Cancer
Via Investor Brand Network
Topics Artificial Intelligence
Biomarkers Could Predict Patients’ Response to Bladder Cancer Therapy
Via Investor Brand Network
Comprehensive Review Shows Gut Microbiome Influences Immunotherapy Efficacy
Via Investor Brand Network
Currently Approved Drug Could Boost Immunotherapy Against Liver Cancer
Via Investor Brand Network
Why Men Need Sexual Health Help While Undergoing Cancer Treatment
Via Investor Brand Network
FIU Researchers Discover New Way of Extending Immune Cell Lifespan and Effectiveness
Via Investor Brand Network
News headline image
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on June 9
Via ACCESS Newswire
New Pill Offers Hope Against Pancreatic Cancer
Via Investor Brand Network
New Inhalable Agent Could Improve Treatment Outcomes in Lung Cancer
Via Investor Brand Network
Scientists Inch Closer to Developing a Lung Cancer Blood Test
Via Investor Brand Network
Researchers Create Less Toxic, More Effective Immunotherapy Against Blood Cancer
Via Investor Brand Network
NHS Starts Offering Immunotherapy Injection to Cancer Patients
Via Investor Brand Network
Study Suggests Timing of Immunotherapy Could Impact Clinical Outcomes
Via Investor Brand Network
Study Finds That Vitamin D Supercharges Chemotherapy Against Breast Cancer
Via Investor Brand Network
Study Uncovers Why the Risk of Breast Cancer Increases with Age
Via Investor Brand Network
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Curious about the most active stocks on Tuesday? ↗
Via Chartmill
Early Trial Suggests mRNA Vaccine Could Be Effective Against Pancreatic Cancer
Via Investor Brand Network
News headline image
RedChip's Biotech Virtual Investor Conference Replays Now Available
Via ACCESS Newswire
New AI Tool Could Boost the Early Detection of Lung Cancer
Via Investor Brand Network
Topics Artificial Intelligence
New Urine Test Boosts Forecasting of Treatment Outcomes in Bladder Cancer
Via Investor Brand Network
Immunotherapy Could Be Boosted by Blocking the Removal of Cancer RNA
Via Investor Brand Network
News headline image
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
Via ACCESS Newswire
Report Forecasts the Cancer Immunotherapy Market Hitting $311.4B by 2031
Via Investor Brand Network
Research Suggests the Thymus is Critical in Immunotherapy Outcomes
Via Investor Brand Network
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.